FDA Plan to Combat Opioid Epidemic Highlights AJPB Week in Review


Top articles of the week from The American Journal of Pharmacy Benefits.

5. Brain Glucose Levels Drop in Patients with Obesity, Diabetes

Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes. Read more.

4. FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma

Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth. Read more.

3. CVS Launches New Performance-Based PBM Network

New network encourages medication adherence for chronic conditions. Read more.

2. Novartis Seeks New Indication for Gene Therapy Kymriah

Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma. Read more.

1. FDA Highlights New Strategies to Combat the Opioid Epidemic

Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic. Read more.

Related Videos
Image Credit: Pixel-Shot | stock.adobe.com
Image credit: Goffkein | stock.adobe.com
Image credit: Wild Awake | stock.adobe.com
Image credit: Dglimages | stock.adobe.com
Home Diabetes Treatment - Image credit: Dglimages | stock.adobe.com
Diabetes patient turn knob on end of insulin pen and dial up correct insulin dose for injection. Scale window on pen syringe showing number of units dose. Medical equipment is easy to self injection - Image credit: Orawan | stock.adobe.com
Patient with diabetes testing blood sugar levels
Bottle and scattered pills on blue backdrop | Image credit: New Africa - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.